Serum copeptin as a diagnostic and prognostic biomarker of coronary artery disease among patients with type 2 diabetes mellitus

Serum copeptin as a diagnostic and prognostic biomarker of coronary artery disease among patients with type 2 diabetes mellitus

Background Diabetes is one of the major risk factors for coronary artery disease (CAD); hormones implicated in cardiac diseases may play a role in diabetes development. Increased activities of the arginine-vasopressin (AVP) system were shown to be associated with type 2 diabetes mellitus (T2DM). The...

Full description

Bibliographic Details
Main Authors:	Nearmeen M Rashad, Tamer M Ezzat, Reem M Allam, Wesam M.R Ashour, Ayman E Ali, Mohamad H Soliman
Format:	Article
Language:	English
Published:	SpringerOpen 2019-01-01
Series:	The Egyptian Journal of Internal Medicine
Subjects:	arginine vasopressin coronary artery disease copeptin type 2 diabetes mellitus
Online Access:	http://www.esim.eg.net/article.asp?issn=1110-7782;year=2019;volume=31;issue=4;spage=696;epage=702;aulast=Rashad

Similar Items

Copeptin analysis in endocrine disorders
by: Nareshni Moodley, et al.
Published: (2023-10-01)

Correlation of copeptin with osmolarity and electrolytes in diabetes Mellitus: A tertiary center outpatient experience.
by: Tooba Noor, et al.
Published: (2022-06-01)

Correlation of copeptin with osmolarity and electrolytes in diabetes Mellitus: A tertiary center outpatient experience.
by: Tooba Noor, et al.
Published: (2022-06-01)

Copeptin in anorexia nervosa
by: Jens P. Goetze, et al.
Published: (2020-04-01)

Copeptin in Growth Hormone-Treated Patients
by: Anna Sjöström, et al.
Published: (2022-09-01)

Preoperative Serum Copeptin Can Predict Delayed Hyponatremia after Pituitary Surgery in the Absence of Arginine Vasopressin Deficiency
by: Ho Kang, et al.
Published: (2024-02-01)

Copeptin as a predictive marker of incident heart failure
by: Fredrika Schill, et al.
Published: (2021-08-01)

Vasopressin marker copeptin and the development of renal and metabolic disorders in patients with type 2 diabetes
by: A. Nesen, et al.
Published: (2022-06-01)

To test, or not to test, and how … copeptin, please advise!
by: Jonas Rutishauser
Published: (2020-07-01)

Copeptin and Stress
by: Marianna Martino, et al.
Published: (2021-10-01)

Copeptin: a novel prognostic biomarker in trauma: a review article
by: Artin Sarkarinejad, et al.
Published: (2023-11-01)

Copeptin does not accurately predict disease severity in imported malaria
by: van Wolfswinkel Marlies E, et al.
Published: (2012-01-01)

Copeptin as a marker of outcome after cardiac arrest: a sub-study of the TTM trial
by: Joachim Düring, et al.
Published: (2020-04-01)

The Effect of Renal Function and Hemodialysis Treatment on Plasma Vasopressin and Copeptin Levels
by: Esmée M. Ettema, et al.
Published: (2017-05-01)

Copeptin Levels Are Independent from Mild Therapeutic Hypothermia but Do Not Predict Infarct Size in Patients Presenting with ST-Segment Elevation Myocardial Infarction
by: Matthias Mueller, et al.
Published: (2021-10-01)

Copeptin concentration in cord blood in infants with early-onset sepsis, chorioamnionitis and perinatal asphyxia
by: Aebi Christoph, et al.
Published: (2011-05-01)

Serum Copeptin levels in the emergency department predict major clinical outcomes in adult trauma patients
by: Fulvio Salvo, et al.
Published: (2020-02-01)

Elevated plasma copeptin levels identify the presence and severity of non-alcoholic fatty liver disease in obesity
by: Ilaria Barchetta, et al.
Published: (2019-04-01)

Limited Role of Endogenous Vasopressin/Copeptin in Stimulation of ACTH–Cortisol Secretion during Glucagon Stimulation Test in Humans
by: Katarzyna Malicka, et al.
Published: (2022-11-01)

The Role of Arginine-Vasopressin in Stroke and the Potential Use of Arginine-Vasopressin Type 1 Receptor Antagonists in Stroke Therapy: A Narrative Review
by: Karol Chojnowski, et al.
Published: (2023-01-01)

A Joint Evaluation of Neurohormone Vasopressin-Neurophysin II-Copeptin and Aortic Arch Calcification on Mortality Risks in Hemodialysis Patients
by: Jia-Feng Chang, et al.
Published: (2020-03-01)

Copeptin Release in Arterial Hypotension and Its Association with Severity of Disease in Critically Ill Children
by: Philipp Baumann, et al.
Published: (2022-05-01)

Copeptin levels increase in response to both insulin-induced hypoglycemia and arginine but not to clonidine: data from GH-stimulation tests
by: Jelena Stankovic, et al.
Published: (2023-10-01)

Plasma copeptin, kidney disease, and risk for cardiovascular morbidity and mortality in two cohorts of type 2 diabetes
by: Gilberto Velho, et al.
Published: (2018-08-01)

Diagnostic and prognostic value of MR-pro ADM, procalcitonin, and copeptin in sepsis
by: Cander Basar, et al.
Published: (2023-12-01)

Prognostic Value of Elevated Copeptin and High-Sensitivity Cardiac Troponin T in Patients with and without Acute Coronary Syndrome: The ConTrACS Study
by: Hanna Waldsperger, et al.
Published: (2020-11-01)

Vasopressin Surrogate Marker Copeptin as a Potential Novel Endocrine Biomarker for Antidepressant Treatment Response in Major Depression: A Pilot Study
by: Agorastos Agorastos, et al.
Published: (2020-05-01)

SIGNIFICANCE OF COPEPTIN IN DIAGNOSTICS OF MYOCARDIAL INFARCTION
by: L. V. Kremneva
Published: (2017-12-01)

Maternal serum copeptin as a marker for fetal growth restriction
by: Ashraf A. Foda, et al.
Published: (2013-09-01)

The stress hormone copeptin: a new prognostic biomarker in acute illness
by: M Christ-Crain
Published: (2010-09-01)

Expression of copeptin and midkine in diabetic retinopathy and their significance
by: Jian-Dan Ren, et al.
Published: (2018-11-01)

Serum copeptin in women with gestational diabetes mellitus: A meta-analysis
by: Yuanqi He, et al.
Published: (2024-03-01)

Low aquaporin-2 excretion in the nephrotic syndrome: an escape from the vasopressin regulating effect
by: Brovko M, et al.
Published: (2018-10-01)

Value of copeptin and C-reactive protein in acute exacerbation of chronic obstructive pulmonary disease
by: Tamer Said Morsi, et al.
Published: (2014-10-01)

Evaluation of diagnostic performance of serum copeptin in correlation with dyslipidemia in Obesed and Non-Obesed type 2 diabetes mellitus (T2DM)
by: Adedeji David Atere, et al.
Published: (2020-10-01)

Evaluation of copeptin and psychological stress among healthcare providers during COVID-19 pandemic
by: Hala M Demerdash, et al.
Published: (2021-01-01)

Performance of Copeptin for Early Diagnosis of Acute Coronary Syndromes: A Systematic Review and Meta-Analysis of 14,139 Patients
by: Lukasz Szarpak, et al.
Published: (2021-12-01)

Involvement of Vasopressin in Tissue Hypoperfusion during Cardiogenic Shock Complicating Acute Myocardial Infarction in Rats
by: Philippe Gaudard, et al.
Published: (2023-01-01)

Serum Copeptin Levels in Adult Patients with a Migraine Attack: A Cross-Sectional Study
by: Ilker Eski, et al.
Published: (2023-09-01)

Copeptin as a Diagnostic and Prognostic Biomarker in Cardiovascular Diseases
by: Danni Mu, et al.
Published: (2022-07-01)